Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...

SCI Ventures’ investment in Precision reflects the firm's belief in the potential impact of the BCI field. The fund provides not only capital but also deep networks of clinicians, regulatory experts, ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in ...

Sam Altman has tapped Mikhail Shapiro, an award-winning biomolecular engineer, to join the Merge Labs brain-computer ...

OpenAI is working on something big, developing its own brain-computer interface. But what does this actually mean?

The post Sam Altman Reportedly Developing Noninvasive Brain Interface to Rival Elon Musk’s Neuralink appeared first on ...

The federal government’s National Reconstruction Fund Corporation is “bringing an Australian company home”, investing $54m in ...

The National Reconstruction Fund has taken a $54 million stake in Synchron, the Melbourne-founded startup developing a ...

In this system, the implanted computer chip would not just sit on the brain, but become part of the brain. Using a technology ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.